Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergyDeepak Mishra, Rachid Drissi, Shelli M. Morris et al.|Neuro-Oncology Advances|2025Cited by 5
IMMU-09. Interim analysis from BrainChild-03: Seattle Children’s Locoregional B7-H3 CAR T Cell Trial for Children with Recurrent Central Nervous System Tumors and DIPGNicholas A. Vitanza, Julie Park, Juliane Gust et al.|Neuro-Oncology|2022Cited by 1
IMMU-13. PRECLINICAL EFFICACY OF MULTI-ANTIGEN (HER2/EGFR806/B7-H3/IL13RA2) TARGETING QUAD-CAR T CELLS AGAINST DIFFUSE MIDLINE GLIOMACarrie Myers, Nicholas A. Vitanza, Kamila Gwiazda et al.|Neuro-Oncology|2023Cited by 1
Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain TumorsRachid Drissi, Shelli M. Morris, Dean Popovski et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0